1Bernard GR, Artigas A, Brigham KL, et al. Report of the American-European consensus conference on ARDS:definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med,1994, 20: 225-232.
2Allen GL, Menendez IY, Ryan MA, et al. Hyperoxia synergistically increases TNF-alpha-induced interleukin-8 gene expression in A549 cells. Am J Physiol Lung Cell Mol Physiol,2000,278:L253-L260.
3Strieter RM, Kunkel SL, Keane MP, et al. Chemokines in lung injury. Chest. 1999,116:103S-110S.
4Beck GC. Yard BA, Breedijk AJ, et al. Release of CXC-chemokines by human lung mierovascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells. Clin Exp Immunol, 1999, 118, 298-303.
5Bauer TT, Monton C, Torres A, et al. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax ,2000,55:46-52.
6Takala A, Jousela I, Takkunen O, et al. A prospective study of inflammation markers in patients at risk of indirect acute lung injury. Shock, 2002,17:252-257.
7Park WY, Goodman RB, Steinberg KP, et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med, 2001, 164:1896-1903.
8Hermans C, Bernard A, Lung epithelium-specific proteins:characteristics and potential application as markers. Am J Respit Crit Care Med,1999, 159:646-678.
9Gunther A, Ruppert C, Schmidt R, et al. Surfactant alteration and replacement in acute respiratory distress syndrome.Respir Res, 2001, 2:353-364.
10Bersten AD, Hunt T, Nicholas TE, et al. Elevated Plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failure.Am J Respir Crit Care Med, 2001,164: 648-652.
